By 2060, nearly 60% of US population will be composed of people with skin of color.1
Over the decades, laser treatment has presented challenges in patients with skin of color.
Recent laser development have significantly minimized these risks by reducing thermal impact.
Millisecond Domain
Scarring, thermal damage.4
Nanosecond Domains
Reduced collateral damage, but still had hypopigmentation, hyperpigmentation, and scarrig.4,5
Picosecond Domain
Minimal risk of hypopigmentation and scarring.4
Nanosecond lasers have restrictive use in skin of color due to the significant risk of PIH. With QS lasers, skin of color has a 25% risk of developing PIH.5 Risk is reported to increase to 47% when the treatment is specific for lentigines, possibly due to the melanocytic hyperplasia noted histologically in a lentigo.5
Picosecond lasers can be used in a broader range of skin types than nanosecond lasers due to reduced risk of hyper- or hypopigmentation and scarring with picosecond photoacoustic versus photothermal effect. Shorter pulses and enhanced photoacoustic effect avoids overheating of skin and decreases risk of PIH. In skin of color, a clinical study with the picosecond laser demonstrated a low rate of PIH, at only 4.65% of the lesions.6
Laser treatment considerations include:7,8
Remove boldy. Treat lightly.
The PicoWay® system delivers high peak power and the shortest pulse durations for a non-thermal, photoacoustic effect that transforms skin from the inside out.2,3,9-11
Still have questions about treating skin of color? Our reps have a wealth of additional tools that can help you learn more.
We invite you to hear industry experts share their insights and experience treating skin of color patients using the PicoWay system.
Still have questions about treating skin of color? Our reps have a wealth of additional tools that can help you learn more.